One study using MMTV-neu transgenic mice found no significant difference in the tumor incidence or onset in Prevastein-treated mice compared to control mice [96] while the other study found that tumor multiplicity and size increased in the medium- and high-Prevastein groups compared to controls [91]. Here, ERBB2 is linked to neoplasm.